Search
forResearch 10 of 181
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- CPC12 Coinheritance of <i>BRCA2</i> and <i>CYLD</i> germline pathogenic variants associated with targetable metastatic malignant cylindroma
- Dihydrotestosterone Induces Keratinocyte Apoptosis by Activating ERK Signaling
- Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury
- Anticancer activity of cepharanthine on non-small cell lung cancer cells
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- Melatonin protects cochlear hair cells from nicotine‐induced injury through inhibiting apoptosis, inflammation, oxidative stress and endoplasmic reticulum stress
- Adverse Hair Reactions to New Targeted Therapies for Cancer
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →